Related references
Note: Only part of the references are listed.Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
Shao-Juan Wang et al.
EMERGING MICROBES & INFECTIONS (2021)
Hepatitis B virus pregenomic RNA status can reveal the long-term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues
Hao Luo et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
Xiaomei Wang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
Hao Luo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA
En-Qiang Chen et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy
Hao Liao et al.
ANTIVIRAL THERAPY (2019)
Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection
M. -L. Wang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Hepatitis B Virus Serum DNA and RNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection
Emily K. Butler et al.
HEPATOLOGY (2018)
Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naive HBV-infected individuals
Hongxin Huang et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues
B. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Reply to: Serum HBV pgRNA as a clinical marker for cccDNA activity Consistent loss of serum HBV RNA might predict the para-functional cure of chronic hepatitis B
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2017)
On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy
Yi-Jie Huang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2017)
Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs
Fengmin Lu et al.
FRONTIERS OF MEDICINE (2017)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
Quantification of HBsAg in nucleos(t)ide-naive patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study
Fabien Zoulim et al.
JOURNAL OF HEPATOLOGY (2015)
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
Cheng-Yuan Peng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2015)
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir
Robert G. Gish et al.
ANTIVIRAL THERAPY (2013)
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B
Milan J. Sonneveld et al.
HEPATOLOGY (2012)
Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels
J. W. Shin et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Correlation of Serum Hepatitis B Surface Antigen Level With Response to Entecavir in Naive Patients With Chronic Hepatitis B
Myoung Hee Lee et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Grading and staging systems for inflammation and fibrosis in chronic liver diseases
Zachary D. Goodman
JOURNAL OF HEPATOLOGY (2007)
Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
T Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
